Click below for our most Frequently Asked Questions about LATISSE® Eyelash Growth Serum. If you can’t find what you are looking for, get in touch with us so we can better assist you.

How is LATISSE® solution different from other eyelash growth products?

LATISSE® is the first FDA-approved prescription treatment to grow lashes for people with inadequate or not enough eyelashes.

What does FDA approved mean?

The US Food and Drug Administration (FDA) is the federal governmental agency charged with protecting the health and welfare of the US public by regulating prescription products. FDA regulations are extremely stringent, and when a drug is FDA approved, that means its efficacy and safety have been scientifically studied in valid clinical trials. FDA approval also requires the sponsoring pharmaceutical company to record all adverse events reported after the drug is approved. LATISSE® received its FDA approval in December 2008

What is hypotrichosis of the eyelashes?

Hypotrichosis is another name for having inadequate or not enough eyelashes.

How does it work?

LATISSE® is believed to prolong the active growth phase,, but the exact way it works is unknown.

How do I apply the product?

LATISSE® should be applied every night using only the accompanying sterile applicators. They should start by ensuring their face is clean, all makeup is removed, and their contact lenses are removed (if applicable). Then carefully place one drop of LATISSE® solution on the disposable sterile applicator and brush cautiously along the skin of the upper eyelid margin at the base of the eyelashes. If any LATISSE®solution gets into the eye, it is not expected to cause harm. The eye should not be rinsed. Patients should be informed not to apply to the lower eyelash line. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material.

How should I handle the bottle and applicators?

The LATISSE® bottle must be maintained intact and to avoid allowing the tip of the bottle or applicator to contact surrounding structures, fingers, or any other unintended surface in order to avoid contamination of the bottle or applicator by common bacteria known to cause ocular infections. Patients should also be instructed to only use the applicator supplied with the product once and then discard it, since reuse could result in using a contaminated applicator. Serious infections may result from using contaminated solutions or applicators.

Who should not use LATISSE® solution?

LATISSE® solution should not be used if you are allergic to one of its ingredients.

Who should I tell if I’m using LATISSE®?

You should tell your physician they are using LATISSE® especially if they have a history of eye pressure problems. They should also tell anyone conducting an eye pressure screening that they are using LATISSE® solution.

Are there any special warnings associated with LATISSE® use?

LATISSE® solution is intended for use on the skin of the upper eyelid margin at the base of the eyelashes. DO NOT APPLY to the lower lid.

LATISSE® solution is intended for use on the skin of the upper eyelid margin at the base of the eyelashes. DO NOT APPLY to the lower lid.

If you are using LUMIGAN® (bimatoprost ophthalmic solution) or other products in the same class used for elevated intraocular pressure (IOP), or if they have a history of abnormal IOP, one should only use LATISSE® after consulting your physician.

LATISSE® use may cause darkening of the eyelid skin, which may be reversible. LATISSE® use may also cause increased brown pigmentation of the colored part of the eye, which is likely to be permanent.

It is possible for hair growth to occur in other areas of the skin that LATISSE® frequently touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material to reduce the chance of this happening. It is also possible for a difference in eyelash length, thickness, fullness, pigmentation, number of eyelash hairs, and/or direction of eyelash growth to occur between eyes. These differences, should they occur, will usually go away if the patient stops using LATISSE® solution.

What are the most frequently reported adverse events in the clinical study?

The most frequently reported adverse events were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and erythema of the eyelid. These events occurred in less than 4% of patients.

Is there potential for eyelid skin darkening?

Skin hyperpigmentation (or skin darkening) is a less common side effect that typically occurs close to where the solution is applied. The eyelid skin may look a little darker due to an increase of melanin in the skin. This is expected to reverse after several weeks to months if the patient stops using the product.

What if I stop using LATISSE®?

Your lashes are expected to return to their previous appearance over several weeks to months.

Why do contact lenses need to be removed before applying?

It’s recommended that you remove your contact lenses because LATISSE® solution contains benzalkonium chloride (BAK), and this may be absorbed by soft contact lenses. Contacts may be reinserted 15 minutes following LATISSE® administration.

Can I continue to use mascara while using LATISSE®?

Yes, you can use mascara in addition to LATISSE® solution.

How soon can I expect results?

It’s important for patients to remember that LATISSE® solution works gradually. While you may start seeing longer lashes after 4 weeks, one must continue the use of LATISSE® every day for 16 weeks for full results. One should not reduce or stop daily application of LATISSE® solution when they first notice results. After 16 weeks, speak with your doctor about ongoing use. Individual results may vary.

What if LATISSE® gets in my eye?

It is not expected to cause harm. Patients don’t need to rinse their eye.

Still Have Questions About LATISSE®?